To mark the publication of the ESMO European Consortium Study on the Availability of Anti-Neoplastic Medicines, ESMO President Elect Josep Tabernero will lead a virtual press conference alongside two of the study’s authors (Alexandru Eniu and Nathan Cherny) to discuss its findings and its role in making progress towards achieving sustainable cancer care for all patients.
Click here to pre-register for this online event taking place at
11.00 – 12.00am CEST on Thursday 21 July 2016
The study, which is being published in the August issue of Annals of Oncology on 26 July 2016, was commissioned as part of ESMO’s commitment to assist national institutions and individual oncologists alike in their clinical decision-making. This European study was designed to give health authorities data to assess whether anti-cancer medicines are available to the patients who are prescribed them, as well as stimulating discussion and debate on this important topic.
Register on this link to join us on 21 July 2016 at 11.00am CEST to hear from some of Europe’s leading oncology experts who will be sharing the results of this snapshot study looking at the complex and important issues of reimbursement, availability and accessibility of anti-cancer medicines.